Effect of flavonoids on cell cycle progression in prostate cancer cells
- 7 January 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 176 (1) , 17-23
- https://doi.org/10.1016/s0304-3835(01)00738-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- p53‐independent Induction of p21 (WAF1/CIP1), Reduction of Cyclin B1 and G2/M Arrest by the Isoflavone Genistein in Human Prostate Carcinoma CellsJapanese Journal of Cancer Research, 2000
- Antioxidant Efficacy of Phytoestrogens in Chemical and Biological Model SystemsArchives of Biochemistry and Biophysics, 1998
- Genistein Induces p21Cip1/WAF1Expression and Blocks the G1 to S Phase Transition in Mouse Fibroblast and Melanoma CellsBiochemical and Biophysical Research Communications, 1998
- Genistein‐induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cellsNutrition and Cancer, 1998
- Genistein‐induced G2‐m arrest, P21WAF1upregulation, and apoptosis in a non‐small‐cell lung cancer cell lineNutrition and Cancer, 1998
- Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigeninMolecular Carcinogenesis, 1997
- The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytesCarcinogenesis: Integrative Cancer Research, 1996
- G1 phase progression: Cycling on cueCell, 1994
- Mammalian G1 cyclinsCell, 1993
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988